Latest Breaking News On - Oxford cannabinoid technologies - Page 2 : comparemela.com

Week ahead: Global PMIs, Fed meeting minutes in focus

Investors' focus over the coming week will be on a raft of global purchasing managers' surveys that may yield useful insights into the strength of the global economy.

United kingdomUnited statesSlovenia generalCity of londonCity ofNova ljubljanska bankaGooch housegoSpiritus mundiTritax euroboxHargreaves lansdownBankers invCarr groupTiton holdingsLloyds banking groupJupiter fund managementChemring group

Oxford Cannabinoid Technologies (LON:OCTP) Hits New 52-Week Low at $0.50

Oxford Cannabinoid Technologies (LON:OCTP) Hits New 52-Week Low at $0.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Oxford cannabinoid technologies company profileOxford cannabinoid technologies holdings plcGet free reportCannabinoid technologies holdings plcOxford cannabinoid technologies dailyOxford cannabinoid technologies

Oxford Cannabinoid Technologies (LON:OCTP) Reaches New 12-Month Low at $0.50

Oxford Cannabinoid Technologies (LON:OCTP) Reaches New 12-Month Low at $0.50
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Oxford Cannabinoid Technologies: Clinical outlook for 2024

Oxford Cannabinoid Technologies: Clinical outlook for 2024
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

Oxford cannabinoid technologiesUnited kingdom basedIrritable bowel syndrome

Oxford Cannabinoid Technologies delighted with phase 1 outcome for pain drug

Clarissa Sowemimo-Coker, CEO of Oxford Cannabinoid Technologies Holdings, discusses with Proactive’s Thomas Warner the successful completion of a phase 1.

Tim coleClarissa sowemimo cokerThomas warnerValentino pribeticOxford cannabinoid technologies holdingsChief medical officerChief scientific officerScientific advisory boardOxford cannabinoid technologies